SCOPUS 정보 검색 플랫폼

International Journal of Antimicrobial Agents

Volumn 16, Issue 2, 2000, Pages 151-156

Concepts in design of comparative clinical trials of antifungal therapy in neutropenic patients

(4) Walsh, Thomas J a Roden, Maureen a Roilides, Emmanuel a Groll, Andreas a

a NATIONAL CANCER INSTITUTE (United States)

Author keywords

Antifungal therapy; Cancer; Neutropenic patients

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE;

ARTICLE; CANDIDIASIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOXICITY; HUMAN; MORTALITY; MYCOSIS; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR;

ANTIFUNGAL AGENTS; CLINICAL TRIALS; HUMAN; MYCOSES; NEUTROPENIA; RESEARCH DESIGN;

EID: 0033776233 PISSN: 09248579 EISSN: None Source Type: Journal
DOI: 10.1016/S0924-8579(00)00242-9 Document Type: Article

Times cited : (5)

References (34)

1
- 0013877409
- Quantitative relationships between circulating leucocytes and infection in patients with leukemia
- (1966) Ann. Intern. Med. , vol.64 , pp. 328
- Bodey, G.P.¹ Buckley, M.² Sathe, Y.S.³

2
- 0013915404
- Fungal infections complicating acute leukemia
- (1966) J. Chron. Dis. , vol.19 , pp. 667
- Bodey, G.P.¹

3
- 0021350050
- Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia
- (1984) Ann. Intern. Med. , vol.100 , pp. 345-351
- Gerson, S.L.¹ Talbot, G.H.² Hurwitz, S.³ Strom, B.L.⁴ Lusk, E.J.⁵ Cassileth, P.B.⁶

4
- 0023837822
- Recurrent fungal pneumonias in patients with acute non-lymphocytic leukemia undergoing multiple courses of intensive chemotherapy
- (1988) Am. J. Med. , vol.84 , pp. 233-239
- Robertson, M.J.¹ Larson, R.A.²

5
- 0026554205
- Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors
- (1992) Cancer , vol.69 , pp. 2653-2662
- Pannuti, C.¹ Gingrich, R.² Pfaller, M.A.³ Kao, C.⁴ Wenzel, R.P.⁵

6
- 0027383450
- Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management
- (1993) Clin. Infect. Dis. , vol.17 , Issue.Suppl 2
- Vartivarian, S.E.¹ Anaissie, E.J.² Bodey, G.P.³

7
- 0027289342
- Management of fever in patients with cancer and treatment-induced neutropenia
- (1993) N. Engl. J. Med. , vol.328 , pp. 1323-1332
- Pizzo, P.A.¹

8
- 0007578581
- Walsh TJ, Groll A. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. J Transplant Infect Dis 2000;1:247-1.

9
- 0028289602
- Human mycoses: drugs and targets for emerging pathogens
- (1994) Science , vol.264 , pp. 371-372
- Georgopapadakou, N.H.¹ Walsh, T.J.²

10
- 0025253978
- Experimental basis for usage of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts
- (1990) Rev. Infect. Dis. , vol.12
- Walsh, T.J.¹ Lee, J.² Aoki, S.³ Mechinaud, F.⁴ Bacher, J.⁵ Lecciones, J.⁶ Thomas, V.⁷ Rubin, M.⁸ Pizzo, P.A.⁹

11
- 0026597735
- A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
- (1992) N. Engl. J. Med. , vol.326 , pp. 845-851
- Goodman, J.L.¹ Winston, D.J.² Greenfield, R.A.³

12
- 0007488630
- Slavin M, Bowden R, Osborne B, Adams R, Levenstein M, Feldman A, Meyers J. [p. 214, abstr. #623]. Fluconazole prophylaxis in marrow transplant recipients. Program and Abstracts of the 1992 Intersci Conf Antimicrob Agents Chemother, American Society for Microbiology, Washington, DC, 1992.

13
- 0028266748
- Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits
- (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 713-718
- Lee, J.W.¹ Amantea, M.² Navarro, E.³ Francis, P.⁴ McManus, E.⁵ Schaufele, R.⁶ Bacher, J.⁷ Pizzo, P.A.⁸ Walsh, T.J.⁹

14
- 0028140216
- Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection
- (1994) J. Infect. Dis. , vol.169 , pp. 356-368
- Francis, P.¹ Lee, J.W.² Hoffman, A.³ Peter, J.⁴ Francesconi, A.⁵ Bacher, J.⁶ Shelhamer, J.⁷ Pizzo, P.⁸ Walsh, T.J.⁹

15
- 0028209901
- Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion (ABCD) in experimental pulmonary aspergillosis
- (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 518-522
- Allende, M.C.¹ Lee, J.W.² Francis, P.³ Garrett, K.⁴ Bacher, J.⁵ Berenguer, J.⁶ Lyman, C.A.⁷ Pizzo, P.A.⁸ Walsh, T.J.⁹

16
- 0029017725
- Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography: a novel non-invasive method for measuring responses of organism-mediated tissue injury
- (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 1065-1069
- Walsh, T.J.¹ Garrett, K.² Feuerstein, E.³ Girton, M.⁴ Allende, M.⁵ Bacher, J.⁶ Francesconi, A.⁷ Schaufele, R.⁸ Pizzo, P.A.⁹

17
- 0029899107
- Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant
- (1996) J. Infect. Dis. , vol.173 , pp. 1208-1215
- Bowden, R.A.¹

18
- 0030984333
- Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis
- (1997) Clin. Infect. Dis. , vol.24 , pp. 635-642
- White, M.H.¹ Anaissie, E.J.² Kusne, S.³ Wingard, J.R.⁴ Hiemenz, J.W.⁵ Cantor, A.⁶ Gurwith, M.⁷ Du Mond, C.⁸ Mamelok, R.D.⁹ Bowden, R.A.¹⁰

19
- 7344264567
- Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia
- (1998) Clin. Infect. Dis. , vol.27 , pp. 296-302
- White, M.H.¹ Bowden, R.A.² Sandler, E.S.³ Graham, M.L.⁴ Noskin, G.A.⁵ Wingard, J.R.⁶ Goldman, M.⁷ van Burik, J.A.⁸ McCabe, A.⁹ Lin, J.S.¹⁰ Gurwith, M.¹¹ Miller, C.B.¹²

20
- 0031716174
- Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 2391-2398
- Walsh, T.J.¹ Yeldandi, V.² McEvoy, M.³ Gonzalez, C.⁴ Chanock, S.J.⁵ Freifeld, A.⁶ Seibel, N.I.⁷ Jarosinski, P.⁸ Boswell, G.⁹ Bekersky, I.¹⁰ Alak, A.¹¹ Buell, D.¹² Barret, J.¹³ Wilson, W.¹⁴

21
- 0007491995
- Walsh TJ, Finberg R, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS, Dismukes WE, for the NIAID-Mycoses Study Group: A randomized, double-blind trial of liposomal amphotericin B versus conventional amphotericin B for empirical antifungal therapy of persistently febrile neutropenic patients. N Engl J Med. 1999;340:764-771.

22
- 0030765063
- Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis
- (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 1944-1948
- Walsh, T.J.¹ Whitcomb, T.² Piscitelli, S.³ Figg, W.D.⁴ Hill, S.⁵ Chanock, S.J.⁶ Jarosinski, P.⁷ Pizzo, P.A.⁸

23
- 0007488632
- Walsh TJ, Seibel NL, Arndt C, Harris R, DiNubile MJ, Reboli A, Hiemenz J, Chanock SJ. Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr Infect Dis J, 1999;18:702-8.

24
- 0007527816
- Guiot HFL, Fibbe WE, van't Wout J. Risk factors for fungal infection in patients with malignant hematological disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994;18:525-32.

25
- 0007491996
- Anaissie EJ, White M, Uzun O, et al. Amphotericin B lipid complex versus amphotericin B for treatment of hematogenous and invasive candidiasis: a prospective, randomized, multicenter trial. Abstracts of the 35th Intersci Conf Antimicrob Agents Chemother, San Francisco, CA, September 17-20, 1995, p. 330, Abstr. LM21.

26
- 0021342283
- Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia
- (1984) Cancer , vol.53 , pp. 411-419
- Schwartz, R.S.¹ Mackintosh, F.R.² Schrier, S.L.³ Greenberg, P.L.⁴

27
- 0020577542
- Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies
- (1983) Am. J. Med. , vol.74 , pp. 934-940
- Gualtieri, R.J.¹ Donowitz, G.R.² Kaiser, D.L.³

28
- 0024450044
- Risk factors for hospital-acquired candidemia: a matched case-control study
- (1979) Arch. Intern. Med. , vol.149 , pp. 2349-2353
- Wey, S.B.¹ Mori, M.² Pfaller, M.A.³ Wolson, R.F.⁴ Wenzel, R.P.⁵

29
- 0022197891
- Fungal infections of the central nervous system: analysis of risk factors and clinical manifestations
- (1985) Neurology , vol.35 , pp. 1654-1657
- Walsh, T.J.¹ Hier, D.B.² Caplan, L.R.³

30
- 4243586366
- Relationship of invasive fungal disease and high-dose cytarabine plus etoposide containing remission-induction regimens for acute myeloid leukemia
- (1991) Blood , vol.78 , Issue.SUPPL.
- Bow, E.J.¹ Shore, T.B.² Kilpatrick, M.G.³ Scott, B.A.⁴ Schacter, B.⁵

31
- 0007533125
- Wingard J, Hiemenz J, Anaissie E et al. Randomized, double blind multicenter study of AmBisome versus Abelcet for empirical antifungal therapy. Focus Fungal Infect 1999;9.

32
- 0007497471
- Ascioglu S, DePauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly P, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis J, Patterson T, Rex JH, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ. Analysis of definitions used in clinical research on invasive fungal infections: consensus proposal for new, standardized definitions. Abstracts of the 39th Intersci Conf Antimicrob Agents Chemother, p. 573, Abstr J-1639, 1999.

33
- 0007567357
- Fundamental of Clinical Trials, 2nd edition, Littleton, MA: PSG
- (1985)
- Friedman, L.M.¹ Furberg, C.D.² DeMets, D.L.³

34
- 0030733419
- Potential new antifungal agents
- (1997) Curr. Opin. Infect. Dis. , vol.10 , pp. 449-458
- Groll, A.¹ Walsh, T.J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.